Éric Jourdan
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 44
- Acute Myeloid Leukemia Research 21
- Multiple Myeloma Research and Treatments 17
- Chronic Myeloid Leukemia Treatments 13
- Hematopoietic Stem Cell Transplantation 6
- Genetics 18
- Chronic Lymphocytic Leukemia Research 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Co-authors
- Bernard Klein (14 shared papers)Jérôme Moreaux (11 shared papers)Éric Legouffe (5 shared papers)Thierry Rème (7 shared papers)Karin Tarte (2 shared papers)John De Vos (13 shared papers)Jean‐François Rossi (8 shared papers)Philippe Le Moine (2 shared papers)
- Journals
- Blood (23 papers)Haematologica (3 papers)Journal of Clinical Oncology (3 papers)British Journal of Haematology (2 papers)Human Gene Therapy (1 paper)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Éric Jourdan
52 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 90
- Hematology 1.3k
- Genetics 407
- Immunology 568
- Oncology 570
- Cancer Research 198
Countries citing papers authored by Éric Jourdan
This map shows the geographic impact of Éric Jourdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Jourdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Jourdan more than expected).
Fields of papers citing papers by Éric Jourdan
This network shows the impact of papers produced by Éric Jourdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Jourdan. The network helps show where Éric Jourdan may publish in the future.
Co-authors
The 25 scholars most cited alongside Éric Jourdan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 429 | |
| 2 | 2005 | 197 | |
| 3 | 2006 | 191 | |
| 4 | 2003 | 175 | |
| 5 | 2016 | 150 | |
| 6 | 2003 | 101 | |
| 7 | 2015 | 87 | |
| 8 | 2005 | 80 | |
| 9 | 2014 | 69 | |
| 10 | 2003 | 57 | |
| 11 | 2010 | 44 | |
| 12 | 2004 | 44 | |
| 13 | 2018 | 41 | |
| 14 | 2005 | 39 | |
| 15 | 2010 | 26 | |
| 16 | 2007 | 26 | |
| 17 | 2012 | 25 | |
| 18 | 2014 | 18 | |
| 19 | 2011 | 17 | |
| 20 | 2015 | 17 |
About Éric Jourdan
Éric Jourdan is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Public Health, Environmental and Occupational Health, having authored 54 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (21 papers), Multiple Myeloma Research and Treatments (17 papers), Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (407 citations), Immunology (568 citations), Oncology (570 citations) and Cancer Research (198 citations). Éric Jourdan has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Bernard Klein, Jérôme Moreaux, Éric Legouffe, Thierry Rème, Karin Tarte, John De Vos, Jean‐François Rossi, Philippe Le Moine, Philippe Quittet and Michel Jourdan. Their work appears in journals such as Blood, Haematologica, Journal of Clinical Oncology, British Journal of Haematology and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.